UC San Diego Study Reveals Accelerated Ageing in Children with MS
UC San Diego study finds accelerated biological ageing in children with MS, highlighting the need for new treatments. Clene Inc. leads in therapeutic innovation.
This research is pivotal as it sheds light on the early onset of ageing-related changes in children with MS, challenging previous understandings of the disease's progression. It emphasizes the critical need for accelerated research and development of treatments tailored for younger patients, potentially altering the trajectory of MS management and improving quality of life for affected individuals and their families.
